CRB
BIIB icon

Chad R. Baker’s Biogen BIIB Stock Holding History

Chad R. Baker’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,995
Closed -$2.79M – 58
2019
Q3 		$2.79M Hold
11,995
– – 0.99% 39
2019
Q2 		$2.81M Hold
11,995
– – 0.98% 38
2019
Q1 		$2.83M Buy
11,995
+8,445
+238% +$2.66M 1.03% 37
2018
Q4 		$1.07M Hold
3,550
– – 0.46% 48
2018
Q3 		$1.25M Hold
3,550
– – 0.46% 49
2018
Q2 		$1.03M Hold
3,550
– – 0.41% 50
2018
Q1 		$972K Buy
+3,550
New +$1.1M 0.38% 51

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Chad R. Baker's BIIB Position: Q4 2019 in Review

Chad R. Baker sold out of Biogen (BIIB) in Q4 2019, closing a stake of 11,995 shares — an estimated $2.79M sold.

Chad R. Baker first reported a position in BIIB in Q1 2018 and held it in 7 quarters. The position peaked at $2.83M in Q1 2019. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Chad R. Baker reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Chad R. Baker sold 11,995 Biogen shares in Q4 2019, an estimated $2.79M.
  • Chad R. Baker first reported a position in Biogen in Q1 2018 and held it in 7 quarters.
  • Chad R. Baker's Biogen position peaked at $2.83M in Q1 2019.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Chad R. Baker's 13F filing for Q4 2019, filed 12 Feb 2020.